Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/35334
Title: Optimizing How We Measure Quality of Life in Drug Hypersensitivity.
Austin Authors: Copaescu, Ana ;Trubiano, Jason 
Affiliation: Centre for Antibiotic Allergy and Research, Department of Infectious Diseases and Immunology, Austin Health, Heidelberg, Victoria, Australia; Department of Medicine, Division of Allergy and Clinical Immunology, McGill University Health Centre (MUHC), McGill University, Montreal, Quebec, Canada; The Research Institute of the McGill University Health Centre, McGill University, Montreal, Quebec, Canada; Department of Infectious Diseases, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, Victoria, Australia.
Centre for Antibiotic Allergy and Research
Infectious Diseases
Issue Date: Jun-2024
Publication information: The journal of allergy and clinical immunology. In practice 2024-06; 12(6)
URI: https://ahro.austin.org.au/austinjspui/handle/1/35334
DOI: 10.1016/j.jaip.2024.03.045
ORCID: 
Journal: The journal of allergy and clinical immunology. In practice
Start page: 1592
End page: 1593
PubMed URL: 38851253
ISSN: 2213-2201
Type: Journal Article
Subjects: Drug Hypersensitivity/diagnosis
Appears in Collections:Journal articles

Show full item record

Page view(s)

54
checked on Dec 1, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.